About Neonatal adrenoleukodystrophy
Neonatal adrenoleukodystrophy is a rare disease catalogued by Orphanet (ORPHA:44). It is associated with the PEX2, PEX1, PEX10 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neonatal adrenoleukodystrophy trials.
Search ClinicalTrials.gov for "Neonatal adrenoleukodystrophy" or filter by Orphanet code ORPHA:44 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neonatal adrenoleukodystrophy trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neonatal adrenoleukodystrophy. Updated daily.